Cutaneous malignant melanoma metastatic to the eyelid

M E Hartstein1, B Biesman, M C Kincaid

  • 1New England Eye Center, Tufts University School of Medicine, Boston, MA, USA.

Ophthalmic Surgery and Lasers
|December 17, 1998
PubMed

Insights

Malignant melanoma rarely spreads to the eyelid, but this case highlights it as a potential first sign of recurrence. Early suspicion of metastasis is crucial in patients with a history of skin cancer.

Area of Science:

  • Ophthalmology
  • Oncology
  • Dermatology

Background:

  • Cutaneous malignant melanoma (CMM) is a significant skin cancer.
  • Metastasis of CMM to ocular and orbital structures is uncommon.
  • Eyelid metastasis from CMM is exceptionally rare.

Observation:

  • A patient with a history of treated melanoma presented with a new eyelid lesion.
  • This eyelid lesion was the initial indicator of tumor recurrence.
  • The patient had no prior history of ocular or orbital melanoma metastasis.

Findings:

  • The eyelid lesion was diagnosed as metastatic malignant melanoma.
  • This represented the first sign of recurrence 3 years after initial treatment for a back melanoma.
  • The patient's prognosis was poor, with death occurring 6 weeks post-diagnosis.

Implications:

  • New eyelid lesions in patients with known malignancy should raise suspicion for metastasis.
  • Metastatic melanoma to the eyelid, though rare, can be an early sign of systemic recurrence.
  • Timely diagnosis and management are critical for patients with suspected melanoma metastasis.